Alterations in Monocyte CD16 in Association with Diabetes Complications
Table 1
Demographic and clinical parameters of control and diabetic subjects with or without complications.
Control
Diabetic
Diabetic
()
()
D−Comps ()
D+Comps ()
Age (yrs)
Duration (yrs)
n.a.
Weight (kg)
BMI (kg/m2)
HbA1c (%)
n.a.
†
Serum creatinine (mol/L)#
66.0 (62.3–80.0)
80.0 (70.0–95.0)*
70.0 (63.5–83.5)
89.5 (79.8–103.8)†
U Alb/Cr ratio (mg/mmol) #
0.7 (0.6–1.2)
1.5 (0.8–3.0)*
0.9 (0.6–1.5)
3.2 (1.9–8.9)†
eGFR (mL/min)
Triglycerides (mmol/L)
HDL cholesterol (mmol/L)
LDL cholesterol (mmol/L)
Sys BP (mmHg)
Dias BP (mmHg)
Results are expressed as mean ± SD, except (#) shown as median with interquartile range (IQR). Significantly different if indicated as (*) for controls versus diabetes and (†) for D−Comps versus D+Comps.